Crossmark

Skene duct adenocarcinoma in a patient with an elevated serum prostate-specific antigen level: a case report

Crossref DOI link: https://doi.org/10.1186/s13256-017-1558-y

Published Online: 2018-02-14

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tsutsumi, Sohgo

Kawahara, Takashi https://orcid.org/0000-0002-7049-3379
Hattori, Yusuke

Mochizuki, Taku

Teranishi, Jun-ichi

Makiyama, Kazuhide

Miyoshi, Yasuhide

Otani, Masako

Uemura, Hiroji
Funding

Funding for this research was provided by:

KAKENHI (16K20152)

Yokohama City University (WJ2810)
More Information

Article History

Received: 11 April 2017

Accepted: 25 December 2017

First Online: 14 February 2018

Ethics approval and consent to participate

: The present study was approved by the institutional review board of Yokohama City University Medical Center.

: Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.